BE
BE · BE · BE-AMP-SAM595484-00
Rybrevant 350 mg
ATC L01FX18
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerJanssen-Cilag International
CountryBE (BE)
ATC codeL01FX18
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 2
- be_apb4430674
- be_apb7749385
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Rybrevant 350 mg",
"name_fr": "Rybrevant 350 mg",
"name_nl": "Rybrevant 350 mg",
"amp_code": "SAM595484-00",
"strengths": [
"50.0000"
],
"pack_count": 1,
"substances": [
"Amivantamab"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Amivantamab",
"authorisation_numbers": [
"EU/1/21/1594/001"
]
}Related drugs
Other records sharing ATC code L01FX18.
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- NORybrevantJanssen-Cilag International N.V.
- PLRybrevantJanssen-Cilag International N.V.
- PLRybrevantJanssen-Cilag International N.V.
- ISRybrevantJanssen-Cilag International NV*
Access this data programmatically
Query Rybrevant 350 mg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.